Summit Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Summit Therapeutics Inc. (SMMT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Operating Activities
Net Income-221.32-614.93-78.78-88.60-52.70
Depreciation & Amortization0.090.201.262.462.00
Stock Based Compensation50.9814.1111.9512.801.77
Change in Working Capital15.48-0.529.87-0.076.76
Change in Accounts Receivable0.540.360.98-1.140.21
Change in Accounts Payable2.022.26-4.13-1.711.64
Change in Other Working Capital12.93527.1720.303.60-6.61
Other Operating Activities12.66527.175.650.82-3.79
Net Cash from Operating Activities-142.11-76.76-41.58-72.59-48.11
Investing Activities
Capital Expenditures-0.14-0.13-0.62-0.310.42
Acquisitions0.000.000.000.00-0.10
Purchases of Investments-680.03-321.020.000.000.00
Sales/Maturities of Investments489.84208.170.000.000.00
Other Investing Activities-15.01-475.020.000.000.00
Net Cash from Investing Activities-205.34-587.77-0.62-0.31-0.42
Financing Activities
Debt Repayment-100.00-24.69-25.00-110.000.00
Common Stock Issued477.89109.69100.4078.0950.00
Other Financing Activities3.33-0.62-0.16-0.17-0.05
Net Cash from Financing Activities381.2386.51620.2477.9250.55
Summary
Effect of Forex Changes on Cash-0.020.84-1.220.350.56
Net Change in Cash33.76-578.02576.825.372.58
Cash at Beginning of Period71.43648.6171.7966.4263.84
Cash at End of Period105.1971.43648.6171.7966.42
Free Cash Flow-142.25-76.89-42.21-72.89-48.53
Supplemental Disclosures
Interest Paid8.8110.650.430.090.00
Income Taxes Paid0.000.050.000.01-0.07